Bendamustine

About

Therapy type: Chemotherapy

Therapy strategy: Alkylating chemotherapy

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) CD20 + Non-Hodgkin Lymphoma Bendamustine, Rituximab
Sensitivity (+) CD20 + Non-Hodgkin Lymphoma Bendamustine, Rituximab
Sensitivity (+) CD30 + Hodgkin Lymphoma Bendamustine, Brentuximab Vedotin